MRK
Merck
PEG ratio, current and historical analysis
- Stocks
- Healthcare
- NYSE: MRK
- PEG Ratio
MRK's PEG ratio cannot be computed because the earnings growth data is negative or zero. Historical data from December 2025 shows Merck with a PEG ratio of 1.8.
MRK PEG ratio history
Merck's eight years historical PEG ratio averages out to 0.54. MRK hit its maximum PEG ratio of 2.66 during the Sep 2018 quarter over the last eight years. The Dec 2024 quarter marked the lowest reading at 0, indicating the most attractive growth-adjusted valuation.
Merck PEG ratio by year
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| 2025 | 1.8 | 14.42 | 8% |
| 2024 | 0 | 14.72 | 4,728.6% |
| 2023 | N/A | 778.71 | -97.6% |
| 2022 | 1.76 | 19.36 | 11% |
| 2021 | 0.17 | 14.85 | 84.9% |
| 2020 | N/A | 29.32 | -27.3% |
| 2019 | 0.37 | 23.68 | 64.1% |
| 2018 | 0.2 | 32.65 | 165.9% |
| 2017 | N/A | 63.94 | -38% |
| 2016 | N/A | 41.46 | -10.1% |
| 2015 | N/A | 33.43 | -61.7% |
| 2014 | 0.08 | 13.78 | 176.5% |
| 2013 | N/A | 33.59 | -26.6% |
| 2012 | N/A | 20.17 | -0.5% |
| 2011 | 0.03 | 18.48 | 628.6% |
Merck PEG ratio by quarter (TTM)
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| Mar 2026 | N/A | 33.69 | -48.2% |
| Dec 2025 | 1.8 | 14.42 | 8% |
| Sep 2025 | 0.19 | 11.09 | 58% |
| Jun 2025 | 0.61 | 12.18 | 20.1% |
| Mar 2025 | 0.02 | 13.03 | 657.1% |
| Dec 2024 | 0 | 14.72 | 4,728.6% |
| Sep 2024 | 0.14 | 23.71 | 164.6% |
| Jun 2024 | 0.07 | 22.88 | 343.4% |
| Mar 2024 | N/A | 145 | -82.3% |
| Dec 2023 | N/A | 778.71 | -97.6% |
| Sep 2023 | N/A | 56.88 | -70% |
| Jun 2023 | N/A | 94.58 | -81.4% |
| Mar 2023 | N/A | 20.74 | -8.6% |
| Dec 2022 | 1.76 | 19.36 | 11% |
| Sep 2022 | 0.13 | 14.28 | 111.6% |
MRK average PEG ratio chart
PEG comparison
MRK EPS growth
MRK Price vs fair value
MRK PEG vs peers
| Stock name | PEG ratio | Market cap |
|---|---|---|
| TEVA Teva Pharmaceutical Industries Ltd | 0.11 | $37.49B |
| LLY ELI LILLY & Co | 0.3 | $1.04T |
| BMY Bristol Myers Squibb Co | 0.46 | $111.7B |
| AMGN Amgen Inc | 0.77 | $186.05B |
| NVS Novartis AG | 2.31 | $284.17B |
| PFE Pfizer Inc | N/A | $142.94B |
| JNJ Johnson & Johnson | N/A | $556.77B |
| ABT Abbott Laboratories | N/A | $152.98B |
| MRK Merck & Co Inc | N/A | $285.22B |
Frequently asked questions
What is Merck's PEG ratio?
MRK's PEG ratio cannot be computed because EPS growth data is negative or not present.
What is the 3-year average PEG ratio for Merck (MRK)?
Historical data over a 3-year period puts MRK's average PEG ratio at 0.4.
What is the 5-year average PEG ratio for Merck (MRK)?
Historical data over a 5-year period puts MRK's average PEG ratio at 0.43.
What is the highest PEG ratio for MRK?
MRK's PEG ratio topped out at 2.66 during the Sep 2018 quarter - the highest in eight years.
All PEG ratio stats are based on quarterly TTM periods, unless otherwise specified.